STD DEV GROUP (01867): Zhao Changsheng and Xu Zhaohong Appointed as Independent Non-Executive Directors

Stock News
2025/09/30

STD DEV GROUP (01867) announced that Mr. Liang Rongjin and Dr. Yan Bing have informed the Board that they will not seek re-election and will retire from their director positions at the conclusion of the Annual General Meeting. Their decision follows consideration of their continuous tenure, the Stock Exchange's independence requirements, and their intention to dedicate more time to personal affairs.

At the Annual General Meeting, shareholders approved the appointment of Mr. Zhao Changsheng and Mr. Xu Zhaohong as independent non-executive directors.

Following the retirement of Mr. Liang and Dr. Yan at the Annual General Meeting, Mr. Liang ceased to serve as Chairman of the Board Remuneration Committee and as a member of both the Board Nomination Committee and Board Audit Committee. Dr. Yan ceased to serve as a member of the Audit Committee.

Effective from the conclusion of the Annual General Meeting, Mr. Zhao has been appointed as Chairman of the Remuneration Committee and as a member of both the Audit Committee and Nomination Committee. Mr. Xu has been appointed as a member of the Audit Committee.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10